North America Infusion Services Market Size and Forecast by Offering, Therapy Type, Administration Route, and Reimbursement Model: 2019-2033

---

North America Infusion Services Market Outlook

• In the year 2025, the North America sector reached USD 173.68 billion, marking a year-over-year growth rate of 4.0%.

• Consensus forecasting indicates that, in 2033, the North America Infusion Services Market is projected to total USD 333.98 billion, with a forecast CAGR of 8.5% for the period.

• Decentralized infusion delivery is accelerating as commercial payers increasingly reimburse home and ambulatory biologic administration to reduce total cost of care, with oncology and autoimmune therapies driving sustained utilization growth across outpatient networks.
• The Centers for Medicare & Medicaid Services continue to maintain home infusion therapy reimbursement under the 21st Century Cures Act framework, reinforcing structural payment support for in-home administration and stabilizing provider participation.

• DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.